BFSG LLC’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93K Sell
5
-5
-50% -$1.85K ﹤0.01% 697
2026
Q1
$2.93K Sell
10
-15
-60% -$4.93K ﹤0.01% 652
2025
Q4
$8.76K Sell
25
-25
-50% -$8.45K ﹤0.01% 556
2025
Q3
$16.2K Hold
50
﹤0.01% 498
2025
Q2
$19.4K Hold
50
﹤0.01% 460
2025
Q1
$21.7K Hold
50
﹤0.01% 439
2024
Q4
$18.4K Hold
50
﹤0.01% 451
2024
Q3
$26K Hold
50
﹤0.01% 423
2024
Q2
$27.1K Hold
50
﹤0.01% 403
2024
Q1
$25.9K Hold
50
﹤0.01% 428
2023
Q4
$23.6K Buy
+50
New +$23.1K ﹤0.01% 404

Other funds holding ELV

BFSG LLC's ELV Position: Q2 2026 in Review

BFSG LLC reduced its Elevance Health (ELV) stake by 50% in Q2 2026, selling an estimated $1.85K and leaving 5 shares worth $1.93K. The position accounts for ﹤0.01% of the portfolio, ranked #697.

BFSG LLC first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $27.1K in Q2 2024. 388 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • BFSG LLC held 5 shares of Elevance Health worth $1.93K as of Q2 2026.
  • BFSG LLC sold 5 Elevance Health shares in Q2 2026, an estimated $1.85K.
  • Elevance Health made up ﹤0.01% of BFSG LLC's portfolio in Q2 2026, its #697 holding.
  • BFSG LLC first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • BFSG LLC's Elevance Health position peaked at $27.1K in Q2 2024.
  • 388 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.